1. COVID-19 threatens M&A already in process— Physician survey shows widespread concern about access to testing and medical supplies for COVID— Novartis cancels $1B generics sale — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

JP Morgan conference

Discussion in 'Acorda Therapeutics' started by anonymous, Jan 15, 2020 at 9:16 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Down 9% day of JP Morgan conference... nuff said!
     

  2. anonymous

    anonymous Guest

    Your CEO revised 2020 Inbrija guidance to a NET of $35M - WEAK. Also revised peak all time sales of $300m which is a pipe dream.... so STFU with your $1B worldwide opportunity. Your lucky to get all time peak sales of $150-200M in the last year of your patent life. And $35M second full year of promotion is a rounding error.
     
  3. anonymous

    anonymous Guest

    overheard at JPM:

    “It looks like old Ronnie is trying to convince people he doesn’t monitor Cafe Pharma”. “What a tool”.
     
  4. anonymous

    anonymous Guest

    Leadership does not have time to read and post here.
     
  5. anonymous

    anonymous Guest

    Actually they read CP forums all the time or read summaries of the posts. They want to know what employees are saying too.
     
  6. anonymous

    anonymous Guest

    Forget what employees are saying, that’s managing in the minors.....they should be more concerned about what Wall Street is saying and it’s not positive.
     
  7. anonymous

    anonymous Guest

    You protest the idea an awful lot Habib. Makes me think there is some truth to it.

    What else do they have to do? They clearly aren’t running the business and they have no money to do meaningful deals.

    Tell everyone hello for us in your “social media” update.
     
  8. anonymous

    anonymous Guest

    The Management does not read the posts on CafePh. No time .
     
  9. anonymous

    anonymous Guest

    Haboob Acor-duhh logic
     
  10. anonymous

    anonymous Guest

    So you keep telling us Habib.

    You seem very concerned about the perception, which indicates it’s true.

    Maybe they should focus on the business instead.
     
  11. anonymous

    anonymous Guest

    overheard at JPM

    “What do you think is the real market opportunity for Inbrija?”

    “Whatever they are willing to give away I guess”

    Great meeting.
     
  12. anonymous

    anonymous Guest

    Pointless posts a waste of time as Leadership does not check into Cpharm.
     
  13. anonymous

    anonymous Guest

    Correct Management does not monitor CP.
     
  14. anonymous

    anonymous Guest

    Correct, they don’t monitor their performance or sales either.... so they are co sister on non-monitoring.
     
  15. anonymous

    anonymous Guest

    overheard at JPM:

    “Isn’t that the CEO who wears Halloween costumes to investor meetings?”

    “Yeah, with his performance you’d think he’d be in a mask all the time”
     
  16. anonymous

    anonymous Guest

    overheard at JPM

    “What did you think of ACORs pitch?”

    “Who?”
     
  17. anonymous

    anonymous Guest

    LOL